← back to search

Jinyuan Xu

Nanjing University of Chinese Medicine · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research focused on Computational biology and Immune system, with related work in Cell type, Annotation, Risk stratification. Notable publications include 'CellMarker: a manually curated resource of cell markers in human and mouse', 'A comprehensive overview of lncRNA annotation resources', and 'Breast cancer prognosis signature: linking risk stratification to disease subtypes'.
h-index
citations
2,523
works
32
NIH funding
primary concept
email

Recent publications

Machine learning models for predicting short-term progression in patients with stage 4 chronic kidney disease: a multi-center validation study
Scientific Reports 2025cited by 2position: middledoi
CRP and HNF1A collaborate to regulate the progression of laryngeal cancer through the Wnt signaling pathway
Functional & Integrative Genomics 2025cited by 1position: middledoi
scPAS: single-cell phenotype-associated subpopulation identifier
Briefings in Bioinformatics 2024cited by 6position: middledoi
Dissecting cellular states of infiltrating microenvironment cells in melanoma by integrating single-cell and bulk transcriptome analysis
BMC Immunology 2023cited by 4position: middledoi
Revealing the contribution of somatic gene mutations to shaping tumor immune microenvironment
Briefings in Bioinformatics 2022cited by 11position: middledoi
The Heterogeneous Cellular States of Glioblastoma Stem Cells Revealed by Single-Cell Analysis
Stem Cells 2022cited by 6position: middledoi
Systematic investigation of the prognostic impact of clonal status of somatic mutations across multiple cancer types
Genomics 2022cited by 1position: lastdoi
Integrated analysis of ferroptosis-related gene signature for overall survival prediction in Asian patients with hepatocellular carcinoma
Clinical & Translational Oncology 2022cited by 1position: middledoi
Identifying Key Somatic Copy Number Alterations Driving Dysregulation of Cancer Hallmarks in Lower-Grade Glioma
Frontiers in Genetics 2021cited by 12position: middledoi
Combination of multiple tumor-infiltrating immune cells predicts clinical outcome in colon cancer
Clinical Immunology 2020cited by 44position: middledoi
Identification of a Six-lncRNA Signature With Prognostic Value for Breast Cancer Patients
Frontiers in Genetics 2020cited by 7position: middledoi
<i>IDH</i> clonal heterogeneity segregates a subgroup of non‐1p/19q codeleted gliomas with unfavourable clinical outcome
Neuropathology and Applied Neurobiology 2020cited by 6position: middledoi
Transcriptome analysis reveals a reprogramming energy metabolism-related signature to improve prognosis in colon cancer
PeerJ 2020cited by 1position: middledoi
Single‐cell RNA‐seq reveals the invasive trajectory and molecular cascades underlying glioblastoma progression
Molecular Oncology 2019cited by 45position: middledoi
Identification of Dysregulated Competitive Endogenous RNA Networks Driven by Copy Number Variations in Malignant Gliomas
Frontiers in Genetics 2019cited by 13position: firstdoi
Single-Cell RNA-Seq Reveals the Invasive Trajectory and Molecular Cascades Underlying Glioblastoma Progression
SSRN Electronic Journal 2019cited by 3position: middledoi
IPEV: a web server for inferring pathogenic enhancers with variants
Research Square 2019cited by 1position: middledoi
Single-cell RNA-seq data reveals TNBC tumor heterogeneity through characterizing subclone compositions and proportions
bioRxiv (Cold Spring Harbor Laboratory) 2019cited by 0position: middledoi
CellMarker: a manually curated resource of cell markers in human and mouse
Nucleic Acids Research 2018cited by 1,700position: middledoi
Breast cancer prognosis signature: linking risk stratification to disease subtypes
Briefings in Bioinformatics 2018cited by 114position: middledoi
Sex difference of mutation clonality in diffuse glioma evolution
Neuro-Oncology 2018cited by 53position: middledoi
Capturing functional long non-coding RNAs through integrating large-scale causal relations from gene perturbation experiments
EBioMedicine 2018cited by 29position: firstdoi
Aberrant Epigenetic Modifications of Non-coding RNAs in Human Disease
Advances in experimental medicine and biology 2018cited by 14position: middledoi
Transcriptome analysis reveals a long non-coding RNA signature to improve biochemical recurrence prediction in prostate cancer
Oncotarget 2018cited by 8position: firstdoi
A comprehensive overview of lncRNA annotation resources
Briefings in Bioinformatics 2016cited by 150position: firstdoi
Systematically characterizing dysfunctional long intergenic non-coding RNAs in multiple brain regions of major psychosis
Oncotarget 2016cited by 53position: middledoi
Dysregulated long intergenic non-coding RNA modules contribute to heart failure
Oncotarget 2016cited by 20position: middledoi
Genome-wide DNA methylome reveals the dysfunction of intronic microRNAs in major psychosis
BMC Medical Genomics 2015cited by 38position: middledoi
Computational identification of epigenetically regulated lncRNAs and their associated genes based on integrating genomic data
FEBS Letters 2015cited by 28position: middledoi
Predicting the Functions of Long Noncoding RNAs Using RNA-Seq Based on Bayesian Network
BioMed Research International 2015cited by 26position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yun Xiao · Xiangya Hospital Central South University20 papers (2014–2022)Xia Li · Beijing Shijitan Hospital17 papers (2014–2022)Yujia Lan · Harbin Medical University14 papers (2015–2023)Lin Pang · Harbin Medical University10 papers (2015–2023)Jing Hu · Wuhan University9 papers (2015–2023)Fulong Yu · Boston Children's Museum8 papers (2015–2018)Yanyan Ping · Harbin Medical University7 papers (2016–2023)Bo Pang · Beijing Tian Tan Hospital6 papers (2019–2023)Jing Bai · Harbin Medical University6 papers (2014–2018)Gaoming Liao · Harbin Medical University5 papers (2018–2022)Min Yan · Jinan University5 papers (2018–2023)Erjie Zhao · Harbin Medical University5 papers (2018–2022)Chaohan Xu · Harbin Medical University4 papers (2014–2019)Jianlong Liao · Harbin Medical University4 papers (2018–2022)Fei Quan · Harbin Medical University4 papers (2018–2020)Liwen Xu · Palo Alto University4 papers (2018–2022)Hongying Zhao · Jiangsu University4 papers (2015–2016)Shiwei Zhu · Harbin Medical University3 papers (2018–2022)Yixue Li · King University3 papers (2018–2020)Tao Luo · Xuzhou Medical College3 papers (2018–2020)